A-胰凝乳蛋白酶原结构式
|
常用名 | A-胰凝乳蛋白酶原 | 英文名 | Chymotrypsinogen |
|---|---|---|---|---|
| CAS号 | 9035-75-0 | 分子量 | N/A | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | N/A | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | N/A |
A-胰凝乳蛋白酶原用途胰凝乳蛋白酶原是胰凝乳蛋白酶(HY-108910)的非活性前体。胰凝乳蛋白酶是一种由胰腺产生的丝氨酸蛋白酶[1][2]。 |
| 中文名 | A-胰凝乳蛋白酶原(限制性化学品禁止进出口) |
|---|---|
| 英文名 | CHYMOTRYPSINOGEN A |
| 英文别名 | 更多 |
| 描述 | 胰凝乳蛋白酶原是胰凝乳蛋白酶(HY-108910)的非活性前体。胰凝乳蛋白酶是一种由胰腺产生的丝氨酸蛋白酶[1][2]。 |
|---|---|
| 相关类别 | |
| 体内研究 | 胰凝乳蛋白酶原因其解决炎症症状的能力而被用于组织修复[2]。 |
| 参考文献 |
| 外观性状 | 白色结晶粉末 |
|---|---|
| 储存条件 | −20°C |
| 个人防护装备 | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| 安全声明 (欧洲) | 22-24/25 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 3 |
|
Protein adsorption, desorption, and aggregation mediated by solid-liquid interfaces.
J. Pharm. Sci. 104 , 1946-59, (2015) Adsorption of proteins to solid-fluid interfaces is often empirically found to promote formation of soluble aggregates and larger, subvisible, and visible particles, but key stages in this process are... |
|
|
Electrodynamic pressure modulation of protein stability in cosolvents.
Biochemistry 52(46) , 8363-73, (2013) Cosolvents affect structural stability of proteins in aqueous solutions. A clear understanding of the mechanism by which cosolvents impact protein stability is critical to understanding protein foldin... |
|
|
Pharmacological inhibition of PAR2 with the pepducin P2pal-18S protects mice against acute experimental biliary pancreatitis.
Am. J. Physiol. Gastrointest. Liver Physiol. 304(5) , G516-26, (2013) Pancreatic acinar cells express proteinase-activated receptor-2 (PAR2) that is activated by trypsin-like serine proteases and has been shown to exert model-specific effects on the severity of experime... |
| EINECS 232-905-3 |
查看所有供应商和价格请点击：